NYSE: EBSEmergent Biosolutions Inc Stock Ownership - Who owns Emergent Biosolutions?
Insider buying vs selling
Have Emergent Biosolutions Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Joseph C. Papa | President and CEO | 2026-03-05 | 37,055 | $8.44 | $312.74kSell |
| Paul Anthony Williams | SVP Products Business | 2026-03-05 | 9,397 | $8.44 | $79.31kSell |
| Coleen Glessner | EVP Quality Ethics and CPL | 2026-03-05 | 8,199 | $8.44 | $69.20kSell |
| William Hartzel | SVP Bioservices | 2026-03-05 | 9,493 | $8.44 | $80.12kSell |
| Jessica Perl | SVP General Counsel Corp Sec | 2026-03-05 | 6,465 | $8.44 | $54.56kSell |
| Richard S. Lindahl | EVP Chief Financial Officer | 2026-03-05 | 23,650 | $8.44 | $199.61kSell |
| Simon C. Lowry | SVP RD CMO | 2026-03-05 | 10,636 | $8.44 | $89.77kSell |
| John D. Fowler Jr. | Director | 2026-03-03 | 5,006 | $8.99 | $45.00kBuy |
| Richard S. Lindahl | EVP Chief Financial Officer | 2026-03-01 | 683 | $8.15 | $5.57kSell |
| Coleen Glessner | EVP Quality Ethics and CPL | 2026-03-01 | 313 | $8.15 | $2.55kSell |
EBS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EBS insiders and whales buy or sell their stock.
EBS Shareholders
What type of owners hold Emergent Biosolutions Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fuad Elhibri | 49.71% | 25,733,310 | $206.12M | Insider |
| Intervac LLC | 8.39% | 4,344,250 | $34.80M | Insider |
| Blackrock Inc | 8.22% | 4,254,397 | $34.08M | Institution |
| Oak Hill Advisors LP | 6.98% | 3,613,338 | $28.94M | Institution |
| Vanguard Group Inc | 6.86% | 3,553,999 | $28.47M | Institution |
| State Street Corp | 5.21% | 2,696,375 | $21.60M | Institution |
| American Century Companies Inc | 4.71% | 2,439,439 | $19.54M | Institution |
| Biopharm LLC | 4.38% | 2,265,043 | $18.14M | Insider |
| Dimensional Fund Advisors LP | 4.35% | 2,252,605 | $18.04M | Institution |
| Robert Calvin Myers | 3.74% | 1,934,849 | $15.50M | Insider |
EBS vs Pharmaceutical Stocks
Emergent Biosolutions Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.